Rejuve Biotech
PrivateLast Round
Crowdfunding
Dec 6, 2024
Est. Valuation
$15M
Total Funding Raised
$4.04M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rejuve Biotech operates in Healthcare & Life Sciences and is based in Orange, California. Its latest recorded funding round was a Crowdfunding round in December 2024.
Rejuve Biotech is a biotechnology company that develops an AI-driven research platform to accelerate the discovery of therapies for aging and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rejuve Biotech Comparables
Compare Rejuve Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fauna Bio | 83% | |
| Gero | 81% | |
| Verge Labs | 74% |
For institutional investors. Book with your work email.
Rejuve Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Dec 6, 2024 | ||||
| Initial Coin Offering | Mar 16, 2023 | ||||
| Seed | Dec 1, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2026
Grew 40% QoQ, from 10 to 14 employees.
- Jun 28, 2026
Grew 30% QoQ, from 10 to 13 employees.
For institutional investors. Book with your work email.
Rejuve Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Rejuve Biotech's valuation, stock price, and market status.
Is Rejuve Biotech a public or private company?
Rejuve Biotech is a private company.
What is the current stock price of Rejuve Biotech?
Rejuve Biotech is a private company, so its shares have no public market price. Caplight tracks Rejuve Biotech's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Rejuve Biotech worth (valuation)?
Rejuve Biotech's valuation is estimated at $15.0M based on funding round data.
Can I buy Rejuve Biotech stock?
Rejuve Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Rejuve Biotech's last funding round?
Rejuve Biotech's most recent funding round was Crowdfunding on December 6, 2024.
Who are the main investors in Rejuve Biotech?
Investor information for Rejuve Biotech is not publicly disclosed.
Will Rejuve Biotech IPO soon?
No public IPO plans have been announced for Rejuve Biotech.
How can I track Rejuve Biotech secondary market activity?
Caplight tracks bids, offers, and trades in Rejuve Biotech's shares on secondary markets.